TITLE:
Combivent CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

CONDITION:
Asthma

INTERVENTION:
Combivent CFC MDI

SUMMARY:

      The purpose of this study is to demonstrate the superior bronchodilator efficacy of inhaled
      Combivent CFC MDI vs. Albuterol HFA MDI in moderate to severe asthma patients.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Patient greater than or equal to 18 years of age,

          -  non-smokers,

          -  diagnosed with asthma, with an FEV1 less than or equal to 70 percent of predicted
             normal,

          -  stable use of Beta agonist

          -  daily use of inhaled steroids for one year

        Exclusion Criteria:

          -  Patients with other significant diseases other than asthma, requiring oxygen,

          -  intubated within 5 years,

          -  asthma exacerbation within 6 weeks of trial,

          -  use of unstable doses (greater than 10 mg/day of prednisone or equivalent) of
             steroids,

          -  participating in another interventional trial
      
